Log in
NYSE:RMED

RA Medical Systems Stock Forecast, Price & News

$0.23
0.00 (0.00 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.21
Now: $0.23
$0.24
50-Day Range
$0.23
MA: $0.30
$0.37
52-Week Range
$0.21
Now: $0.23
$2.69
Volume2.73 million shs
Average Volume3.06 million shs
Market Capitalization$16.94 million
P/E RatioN/A
Dividend YieldN/A
Beta1.17
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.90 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone760-804-1648

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.20 million
Book Value$2.47 per share

Profitability

Net Income$-56,960,000.00
Net Margins-807.30%

Miscellaneous

Employees95
Market Cap$16.94 million
Next Earnings Date12/4/2020 (Estimated)
OptionableNot Optionable
$0.23
0.00 (0.00 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RMED News and Ratings via Email

Sign-up to receive the latest news and ratings for RMED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











RA Medical Systems (NYSE:RMED) Frequently Asked Questions

How has RA Medical Systems' stock price been impacted by Coronavirus?

RA Medical Systems' stock was trading at $1.2563 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RMED shares have decreased by 81.4% and is now trading at $0.2338.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of RA Medical Systems?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RA Medical Systems in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for RA Medical Systems
.

When is RA Medical Systems' next earnings date?

RA Medical Systems is scheduled to release its next quarterly earnings announcement on Friday, December 4th 2020.
View our earnings forecast for RA Medical Systems
.

How were RA Medical Systems' earnings last quarter?

RA Medical Systems Inc (NYSE:RMED) announced its earnings results on Tuesday, August, 11th. The company reported ($0.43) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.22) by $0.21. RA Medical Systems had a negative return on equity of 140.19% and a negative net margin of 807.30%.
View RA Medical Systems' earnings history
.

What price target have analysts set for RMED?

3 Wall Street analysts have issued twelve-month price objectives for RA Medical Systems' stock. Their forecasts range from $1.00 to $2.00. On average, they anticipate RA Medical Systems' share price to reach $1.50 in the next twelve months. This suggests a possible upside of 541.6% from the stock's current price.
View analysts' price targets for RA Medical Systems
.

Are investors shorting RA Medical Systems?

RA Medical Systems saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 2,660,000 shares, an increase of 50.3% from the August 15th total of 1,770,000 shares. Based on an average daily volume of 5,960,000 shares, the short-interest ratio is currently 0.4 days.
View RA Medical Systems' Short Interest
.

Who are some of RA Medical Systems' key competitors?

What other stocks do shareholders of RA Medical Systems own?

Who are RA Medical Systems' key executives?

RA Medical Systems' management team includes the following people:
  • Mr. Dean Irwin, CEO, Chief Technology Officer & Chairman of Director (Age 56)
  • Mr. Jeffrey Jay Kraws, Pres (Age 55)
  • Ms. Melissa Burstein, Exec. VP & Director (Age 43)
  • Mr. Richard Heymann, Director of Corp. Strategy & Bus. Devel. (Age 64)
  • Mr. Andrew C. Jackson, Chief Financial Officer (Age 50)

When did RA Medical Systems IPO?

(RMED) raised $50 million in an initial public offering (IPO) on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor acted as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

What is RA Medical Systems' stock symbol?

RA Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED."

Who are RA Medical Systems' major shareholders?

RA Medical Systems' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Two Sigma Advisers LP (0.28%) and Bridgeway Capital Management Inc. (0.26%). Company insiders that own RA Medical Systems stock include Andrew C Jackson, Dean Irwin, Jeffrey J Kraws, Jonathan Will Mcguire, Martin Burstein, Richard Mejia Jr and William R Enquist.
View institutional ownership trends for RA Medical Systems
.

Which institutional investors are buying RA Medical Systems stock?

RMED stock was purchased by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, and Bridgeway Capital Management Inc.. Company insiders that have bought RA Medical Systems stock in the last two years include Jonathan Will Mcguire, Richard Mejia Jr, and William R Enquist.
View insider buying and selling activity for RA Medical Systems
.

How do I buy shares of RA Medical Systems?

Shares of RMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is RA Medical Systems' stock price today?

One share of RMED stock can currently be purchased for approximately $0.23.

How big of a company is RA Medical Systems?

RA Medical Systems has a market capitalization of $16.94 million and generates $7.20 million in revenue each year. The company earns $-56,960,000.00 in net income (profit) each year or ($4.33) on an earnings per share basis. RA Medical Systems employs 95 workers across the globe.

What is RA Medical Systems' official website?

The official website for RA Medical Systems is www.ramed.com.

How can I contact RA Medical Systems?

RA Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The company can be reached via phone at 760-804-1648 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.